1. Home
  2. NEPH vs HIT Comparison

NEPH vs HIT Comparison

Compare NEPH & HIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • HIT
  • Stock Information
  • Founded
  • NEPH 1997
  • HIT 1964
  • Country
  • NEPH United States
  • HIT United States
  • Employees
  • NEPH N/A
  • HIT N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • HIT Specialty Insurers
  • Sector
  • NEPH Health Care
  • HIT Finance
  • Exchange
  • NEPH Nasdaq
  • HIT Nasdaq
  • Market Cap
  • NEPH 36.1M
  • HIT 37.2M
  • IPO Year
  • NEPH 2004
  • HIT 2024
  • Fundamental
  • Price
  • NEPH $4.03
  • HIT $0.85
  • Analyst Decision
  • NEPH Buy
  • HIT Strong Buy
  • Analyst Count
  • NEPH 1
  • HIT 1
  • Target Price
  • NEPH $5.00
  • HIT $2.50
  • AVG Volume (30 Days)
  • NEPH 67.9K
  • HIT 310.5K
  • Earning Date
  • NEPH 08-07-2025
  • HIT 08-15-2025
  • Dividend Yield
  • NEPH N/A
  • HIT N/A
  • EPS Growth
  • NEPH N/A
  • HIT N/A
  • EPS
  • NEPH 0.08
  • HIT 0.02
  • Revenue
  • NEPH $15,517,000.00
  • HIT $22,380,959.00
  • Revenue This Year
  • NEPH $17.06
  • HIT $58.79
  • Revenue Next Year
  • NEPH $12.20
  • HIT N/A
  • P/E Ratio
  • NEPH $53.08
  • HIT $46.49
  • Revenue Growth
  • NEPH 10.34
  • HIT 11.24
  • 52 Week Low
  • NEPH $1.36
  • HIT $0.51
  • 52 Week High
  • NEPH $5.00
  • HIT $7.59
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 56.63
  • HIT N/A
  • Support Level
  • NEPH $3.83
  • HIT N/A
  • Resistance Level
  • NEPH $4.39
  • HIT N/A
  • Average True Range (ATR)
  • NEPH 0.47
  • HIT 0.00
  • MACD
  • NEPH -0.07
  • HIT 0.00
  • Stochastic Oscillator
  • NEPH 43.27
  • HIT 0.00

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About HIT Health In Tech Inc. Class A Common Stock

Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.

Share on Social Networks: